tiprankstipranks
Trending News
More News >
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market
Advertisement

Madrigal Pharmaceuticals (MDGL) Ownership - Who Owns Madrigal Pharmaceuticals?

Compare
1,261 Followers

Madrigal Pharmaceuticals (MDGL) Ownership Overview

19.50%25.31%<0.01%13.43%41.76%
19.50% Insiders
<0.01% Other Institutional Investors
13.43% ETFs
41.76% Public Companies and Individual Investors
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 38.74% of the company’s stock is owned by Institutional Investors, 19.50% is owned by Insiders, and 41.76% is owned by Public Companies and Individual Investors.
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 25.31% of the company’s stock is owned by Institutional Investors, 19.50% is owned by Insiders, and 13.43% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 14, 2025
xxxxxxxxxxxxx
$5082372
Mar 07, 2025
xxxxxxxxxxxxx
$4817012
Mar 05, 2025
xxxxxxxxxxxxx
$386831
Mar 04, 2025
xxxxxxxxxxxxx
$418480

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$353753
Mar 31, 2025
xxxxxxxxxxxxx
$10485416
Mar 31, 2025
xxxxxxxxxxxxx
$15402195
Mar 31, 2025
xxxxxxxxxxxxx
$105143332

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,099,523Institution9.46%653,245,586
1,974,590Institution8.89%614,373,933
1,796,261Insider8.09%558,888,648
1,638,361Institution7.38%509,759,642
1,465,402Institution6.60%455,945,178
1,405,015Institution6.33%437,156,367
1,116,584Insider5.03%347,413,946
842,704Insider3.80%262,198,923
784,095Institution3.53%243,963,318
383,547Insider1.73%119,336,814

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,465,402Institution6.60%455,945,178
1,405,015Institution6.33%437,156,367
301,554Institution1.36%93,825,512
196,478Institution0.88%61,132,165
190,347Institution0.86%59,224,566
180,644Institution0.81%56,205,574
140,924Institution0.63%43,847,093
130,564Institution0.59%40,623,683
130,559Institution0.59%40,622,127
102,239Institution0.46%31,810,642

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
530,211Institution2.39%145,945,880
425,794Institution1.92%132,481,545
417,728Institution1.88%114,983,809
306,465Institution1.38%96,677,449
268,531Institution1.21%73,915,843
264,836Institution1.19%72,898,757
148,574Institution0.67%46,227,314
121,416Institution0.55%37,777,374
90,860Institution0.41%25,010,124
81,542Institution0.37%25,723,239

FAQ

Who Owns Madrigal Pharmaceuticals Inc (MDGL)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 19.50% is held by insiders, and 41.76% is held by retail investors.
    What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors.
      What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 41.76% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors.
        Who owns the most shares of Madrigal Pharmaceuticals Inc (MDGL)?
        John Paulson owns the most shares of Madrigal Pharmaceuticals Inc (MDGL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis